Genetic Counseling and Genome Sequencing in Pediatric Rare Disease

Overview

Journal Cold Spring Harb Perspect Med

Specialty General Medicine

Date 2019 Sep 11

PMID 31501267

Citations 16

Authors

Alison M Elliott

Affiliations

Soon will be listed here.

Abstract

Both genome sequencing (GS) and exome sequencing (ES) have proven to be revolutionary in the diagnosis of pediatric rare disease. The diagnostic potential and increasing affordability make GS and ES more accessible as a routine clinical test in some centers. Herein, I review aspects of rare disease in pediatrics associated with the use of genomic technologies with an emphasis on the benefits and limitations of both ES and GS, complexities of variant classification, and the importance of genetic counseling. Indications for testing, the role of genetic counselors in genomic test selection, and the diagnostic potential of ES and GS in various pediatric multisystem disorders are discussed. The neonatal population represents an important cohort in pediatric rare disease. Rapid ES and GS in critically ill neonates can have an immediate impact on medical management and present unique genetic counseling challenges. This work includes reviews of recommendations for genetic counseling for families considering genome-wide sequencing, and issues of access to genetic counseling that affect clinical use and will necessitate implementation of innovative methods such as online decision aids. Finally, this work will also review the challenges of having a child with a rare disease, the impact of results from ES and GS on these families, and the role of various support agencies.

Citing Articles

Case Report: The first Korean familial case of -related deafness, dystonia, and cerebral hypomyelination.

Suh Y, Hwang J, Seo G, Khang R, Lee J, Park M Front Pediatr. 2025; 12:1488095.

PMID: 39911770 PMC: 11794251. DOI: 10.3389/fped.2024.1488095.

Characterization of patients treated at a rare disease referral service: a descriptive study, 2016-2021.

Carvalho E, Hopker R, Pedroso G, Almeida L, Pacher J, Antonio A Epidemiol Serv Saude. 2025; 33():e20240204.

PMID: 39776132 PMC: 11660309. DOI: 10.1590/S2237-96222024v33e20240204.en.

Non-Genetic Healthcare Providers' Experiences and Perspectives with Rapid Genome-Wide Sequencing in Canadian Neonatal Intensive Care Units.

Piers L, Wainstein T, Pelligra G, Osiovich H, GenCOUNSEL Study , Elliott A Children (Basel). 2024; 11(8).

PMID: 39201845 PMC: 11352610. DOI: 10.3390/children11080910.

Clinical description and evaluation of 30 pediatric patients with ultra-rare diseases: A multicenter study with real-world data from Saudi Arabia.

Muthaffar O, Alazhary N, Alyazidi A, Alsubaie M, Bahowarth S, Odeh N PLoS One. 2024; 19(7):e0307454.

PMID: 39024300 PMC: 11257271. DOI: 10.1371/journal.pone.0307454.

Refined preferences of prioritizers improve intelligent diagnosis for Mendelian diseases.

Yuan X, Su J, Wang J, Dai B, Sun Y, Zhang K Sci Rep. 2024; 14(1):2845.

PMID: 38310124 PMC: 10838329. DOI: 10.1038/s41598-024-53461-x.

References

Lewis M, Paquin R, Roche M, Furberg R, Rini C, Berg J . Supporting Parental Decisions About Genomic Sequencing for Newborn Screening: The NC NEXUS Decision Aid. Pediatrics. 2016; 137 Suppl 1:S16-23. PMC: 4922487. DOI: 10.1542/peds.2015-3731E. View

Wright C, McRae J, Clayton S, Gallone G, Aitken S, Fitzgerald T . Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders. Genet Med. 2018; 20(10):1216-1223. PMC: 5912505. DOI: 10.1038/gim.2017.246. View

Tarailo-Graovac M, Shyr C, Ross C, Horvath G, Salvarinova R, Ye X . Exome Sequencing and the Management of Neurometabolic Disorders. N Engl J Med. 2016; 374(23):2246-55. PMC: 4983272. DOI: 10.1056/NEJMoa1515792. View

Tolusso L, Collins K, Zhang X, Holle J, Valencia C, Myers M . Pediatric Whole Exome Sequencing: an Assessment of Parents' Perceived and Actual Understanding. J Genet Couns. 2016; 26(4):792-805. DOI: 10.1007/s10897-016-0052-9. View

Sheehan J, Sherman K . Computerised decision aids: a systematic review of their effectiveness in facilitating high-quality decision-making in various health-related contexts. Patient Educ Couns. 2011; 88(1):69-86. DOI: 10.1016/j.pec.2011.11.006. View

Johnston J, Farrell R, Parens E . Supporting Women's Autonomy in Prenatal Testing. N Engl J Med. 2017; 377(6):505-507. PMC: 5688876. DOI: 10.1056/NEJMp1703425. View

Green R, Berg J, Grody W, Kalia S, Korf B, Martin C . ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013; 15(7):565-74. PMC: 3727274. DOI: 10.1038/gim.2013.73. View

Wenger A, Guturu H, Bernstein J, Bejerano G . Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers. Genet Med. 2016; 19(2):209-214. DOI: 10.1038/gim.2016.88. View

David K, Best R, Brenman L, Bush L, Deignan J, Flannery D . Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018; 21(4):769-771. DOI: 10.1038/s41436-018-0391-z. View

10.

Sapp J, Dong D, Stark C, Ivey L, Hooker G, Biesecker L . Parental attitudes, values, and beliefs toward the return of results from exome sequencing in children. Clin Genet. 2013; 85(2):120-6. PMC: 3930614. DOI: 10.1111/cge.12254. View

11.

Carrieri D, Howard H, Benjamin C, Clarke A, Dheensa S, Doheny S . Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics. Eur J Hum Genet. 2018; 27(2):169-182. PMC: 6336881. DOI: 10.1038/s41431-018-0285-1. View

12.

Spillmann R, McConkie-Rosell A, Pena L, Jiang Y, Schoch K, Walley N . A window into living with an undiagnosed disease: illness narratives from the Undiagnosed Diseases Network. Orphanet J Rare Dis. 2017; 12(1):71. PMC: 5392939. DOI: 10.1186/s13023-017-0623-3. View

13.

Baird P, Anderson T, Newcombe H, Lowry R . Genetic disorders in children and young adults: a population study. Am J Hum Genet. 1988; 42(5):677-93. PMC: 1715177. View

14.

Chourasia N, Surianarayanan P, Adhisivam B, Vishnu Bhat B . NICU admissions and maternal stress levels. Indian J Pediatr. 2012; 80(5):380-4. DOI: 10.1007/s12098-012-0921-7. View

15.

Yanes T, Humphreys L, McInerney-Leo A, Biesecker B . Factors Associated with Parental Adaptation to Children with an Undiagnosed Medical Condition. J Genet Couns. 2017; 26(4):829-840. PMC: 5493508. DOI: 10.1007/s10897-016-0060-9. View

16.

Wynn J, Ottman R, Duong J, Wilson A, Ahimaz P, Martinez J . Diagnostic exome sequencing in children: A survey of parental understanding, experience and psychological impact. Clin Genet. 2017; 93(5):1039-1048. PMC: 5899627. DOI: 10.1111/cge.13200. View

17.

Amberger J, Bocchini C, Schiettecatte F, Scott A, Hamosh A . OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2014; 43(Database issue):D789-98. PMC: 4383985. DOI: 10.1093/nar/gku1205. View

18.

Knoppers B, Zawati M, Senecal K . Return of genetic testing results in the era of whole-genome sequencing. Nat Rev Genet. 2015; 16(9):553-9. DOI: 10.1038/nrg3960. View

19.

Hennekam R . Care for patients with ultra-rare disorders. Eur J Med Genet. 2010; 54(3):220-4. DOI: 10.1016/j.ejmg.2010.12.001. View

20.

Yee L, Wolf M, Mullen R, Bergeron A, Bailey S, Levine R . A randomized trial of a prenatal genetic testing interactive computerized information aid. Prenat Diagn. 2014; 34(6):552-7. PMC: 4043849. DOI: 10.1002/pd.4347. View